GH Research (NASDAQ:GHRS) Shares Gap Up Following Analyst Upgrade

GH Research PLC (NASDAQ:GHRS)’s stock price gapped up prior to trading on Monday after Canaccord Genuity Group raised their price target on the stock from $30.00 to $31.00. The stock had previously closed at $11.68, but opened at $12.30. Canaccord Genuity Group currently has a buy rating on the stock. GH Research shares last traded at $11.92, with a volume of 12,509 shares trading hands.

A number of other equities analysts also recently commented on the company. JMP Securities lowered their price objective on GH Research from $50.00 to $39.00 and set a “market outperform” rating for the company in a research report on Friday, March 1st. HC Wainwright reissued a “buy” rating and issued a $40.00 target price on shares of GH Research in a report on Monday, March 4th.

Institutional Trading of GH Research

Institutional investors have recently modified their holdings of the stock. AdvisorShares Investments LLC lifted its position in GH Research by 4.3% in the fourth quarter. AdvisorShares Investments LLC now owns 48,300 shares of the company’s stock valued at $280,000 after acquiring an additional 1,977 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of GH Research by 16.2% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 92,784 shares of the company’s stock valued at $932,000 after purchasing an additional 12,911 shares during the last quarter. PEAK6 Investments LLC boosted its position in shares of GH Research by 72.9% in the 3rd quarter. PEAK6 Investments LLC now owns 40,308 shares of the company’s stock valued at $405,000 after purchasing an additional 16,991 shares during the period. Barclays PLC grew its stake in GH Research by 98.2% during the 3rd quarter. Barclays PLC now owns 63,590 shares of the company’s stock worth $640,000 after buying an additional 31,500 shares during the last quarter. Finally, Lynx1 Capital Management LP lifted its stake in GH Research by 13.8% in the third quarter. Lynx1 Capital Management LP now owns 1,103,178 shares of the company’s stock valued at $11,087,000 after buying an additional 133,804 shares during the last quarter. Hedge funds and other institutional investors own 56.90% of the company’s stock.

GH Research Stock Up 3.3 %

The firm has a market capitalization of $628.52 million, a price-to-earnings ratio of -18.87 and a beta of 0.80. The company has a fifty day moving average price of $10.45 and a two-hundred day moving average price of $8.04.

GH Research (NASDAQ:GHRS) last released its quarterly earnings results on Thursday, February 29th. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.20) by ($0.01). On average, equities analysts anticipate that GH Research PLC will post -0.96 earnings per share for the current fiscal year.

About GH Research

GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurological disorders. It is involved in the development of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD).